404 related articles for article (PubMed ID: 16258731)
1. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis.
Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ
Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731
[TBL] [Abstract][Full Text] [Related]
2. Update of alpha fetoprotein growth-inhibitory peptides as biotherapeutic agents for tumor growth and metastasis.
Mizejewski GJ; Muehlemann M; Dauphinee M
Chemotherapy; 2006; 52(2):83-90. PubMed ID: 16498241
[TBL] [Abstract][Full Text] [Related]
3. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
Mizejewski G; Smith G; Butterstein G
Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
[TBL] [Abstract][Full Text] [Related]
4. The alpha-fetoprotein-derived growth inhibitory peptide 8-mer fragment: review of a novel anticancer agent.
Mizejewski GJ
Cancer Biother Radiopharm; 2007 Feb; 22(1):73-98. PubMed ID: 17627416
[TBL] [Abstract][Full Text] [Related]
5. Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides: review and prospects.
Mizejewskia GJ; Butterstein G
Curr Protein Pept Sci; 2006 Feb; 7(1):73-100. PubMed ID: 16472170
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of anti-cancer growth inhibitory peptides derived from human alpha-fetoprotein: review of an International Multi-Center Collaborative Study.
Mizejewski GJ; Mirowski M; Garnuszek P; Maurin M; Cohen BD; Poiesz BJ; Posypanova GA; Makarov VA; Severin ES; Severin SE
J Drug Target; 2010 Sep; 18(8):575-88. PubMed ID: 20151941
[TBL] [Abstract][Full Text] [Related]
7. Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: relevance to physicochemical properties.
Mizejewski GJ; Eisele L; Maccoll R
Anticancer Res; 2006; 26(4B):3071-6. PubMed ID: 16886636
[TBL] [Abstract][Full Text] [Related]
8. Synthetic peptides and tumor cell metastasis.
Fields GB
Pept Res; 1993; 6(3):115-20. PubMed ID: 8318740
[TBL] [Abstract][Full Text] [Related]
9. Possible mechanism of inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid: nucleoside conjugate.
Kijima-Suda I; Miyazawa T; Itoh M; Toyoshima S; Osawa T
Cancer Res; 1988 Jul; 48(13):3728-32. PubMed ID: 3288333
[TBL] [Abstract][Full Text] [Related]
10. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
11. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
Bourguignon LY; Gunja-Smith Z; Iida N; Zhu HB; Young LJ; Muller WJ; Cardiff RD
J Cell Physiol; 1998 Jul; 176(1):206-15. PubMed ID: 9618160
[TBL] [Abstract][Full Text] [Related]
12. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone.
van der Pluijm G; Vloedgraven HJ; Ivanov B; Robey FA; Grzesik WJ; Robey PG; Papapoulos SE; Lowik CW
Cancer Res; 1996 Apr; 56(8):1948-55. PubMed ID: 8620518
[TBL] [Abstract][Full Text] [Related]
13. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
[TBL] [Abstract][Full Text] [Related]
14. Definition of a sequence, RYVVLPR, within laminin peptide F-9 that mediates metastatic fibrosarcoma cell adhesion and spreading.
Skubitz AP; McCarthy JB; Zhao Q; Yi XY; Furcht LT
Cancer Res; 1990 Dec; 50(23):7612-22. PubMed ID: 2253210
[TBL] [Abstract][Full Text] [Related]
15. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
DeFreest LA; Mesfin FB; Joseph L; McLeod DJ; Stallmer A; Reddy S; Balulad SS; Jacobson HI; Andersen TT; Bennett JA
J Pept Res; 2004 May; 63(5):409-19. PubMed ID: 15140158
[TBL] [Abstract][Full Text] [Related]
16. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
17. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
18. Role of cell surface oligosaccharides of mouse mammary tumor cell lines in cancer metastasis.
Zhao Y; Li J; Wang J; Xing Y; Geng M
Indian J Biochem Biophys; 2007 Jun; 44(3):145-51. PubMed ID: 17650582
[TBL] [Abstract][Full Text] [Related]
19. Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma.
Menez J; Le Maux Chansac B; Dorothée G; Vergnon I; Jalil A; Carlier MF; Chouaib S; Mami-Chouaib F
Oncogene; 2004 Apr; 23(15):2630-9. PubMed ID: 15048094
[TBL] [Abstract][Full Text] [Related]
20. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
